Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lambin

Showing results (661-670 of 939) with videos related to

Pageof 94
Sort By:
Scientific Reports|August 8, 2015
Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancerChintan Parmar, Ralph T H Leijenaar, Patrick Grossmann, et al.
The Science of the Total Environment|July 9, 2016
Rate of exposure of a sentinel species, invasive American mink (Neovison vison) in Scotland, to anticoagulant rodenticidesNorberto Ruiz-Suárez, Yolanda Melero, Anna Giela, et al.
The British Journal of Radiology|May 26, 2017
Combining radiotherapy with immunotherapy: the past, the present and the futureEvert J Van Limbergen, Dirk K De Ruysscher, Veronica Olivo Pimentel, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 19, 2018
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytesAshok Aspatwar, Holger M Becker, Nanda Kumar Parvathaneni, et al.
Cancers|May 28, 2020
Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation TracerSebastian Sanduleanu, Alexander M A van der Wiel, Relinde I Y Lieverse, et al.
Medical Physics|August 11, 2006
A Monte Carlo based three-dimensional dose reconstruction method derived from portal dose imagesWouter J C van Elmpt, Sebastiaan M J J G Nijsten, Robert F H Schiffeleers, et al.
Oncotarget|April 24, 2018
Results and adverse events of personalized peptide receptor radionuclide therapy with <sup>90</sup>Yttrium and <sup>177</sup>Lutetium in 1048 patients with neuroendocrine neoplasmsRichard P Baum, Harshad R Kulkarni, Aviral Singh, et al.
Scientific Reports|March 20, 2019
Stability of radiomics features in apparent diffusion coefficient maps from a multi-centre test-retest trialJurgen Peerlings, Henry C Woodruff, Jessica M Winfield, et al.
Journal for Immunotherapy of Cancer|March 10, 2021
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapyVeronica Olivo Pimentel, Damiënne Marcus, Alexander Ma van der Wiel, et al.
Scientific Reports|August 6, 2015
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysisRalph T H Leijenaar, Georgi Nalbantov, Sara Carvalho, et al.
Pageof 94

Showing results (661-670 of 939) with videos related to

Sort By:
Pageof 94
Scientific Reports|August 8, 2015
Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancerChintan Parmar, Ralph T H Leijenaar, Patrick Grossmann, et al.
The Science of the Total Environment|July 9, 2016
Rate of exposure of a sentinel species, invasive American mink (Neovison vison) in Scotland, to anticoagulant rodenticidesNorberto Ruiz-Suárez, Yolanda Melero, Anna Giela, et al.
The British Journal of Radiology|May 26, 2017
Combining radiotherapy with immunotherapy: the past, the present and the futureEvert J Van Limbergen, Dirk K De Ruysscher, Veronica Olivo Pimentel, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 19, 2018
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytesAshok Aspatwar, Holger M Becker, Nanda Kumar Parvathaneni, et al.
Cancers|May 28, 2020
Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation TracerSebastian Sanduleanu, Alexander M A van der Wiel, Relinde I Y Lieverse, et al.
Medical Physics|August 11, 2006
A Monte Carlo based three-dimensional dose reconstruction method derived from portal dose imagesWouter J C van Elmpt, Sebastiaan M J J G Nijsten, Robert F H Schiffeleers, et al.
Oncotarget|April 24, 2018
Results and adverse events of personalized peptide receptor radionuclide therapy with <sup>90</sup>Yttrium and <sup>177</sup>Lutetium in 1048 patients with neuroendocrine neoplasmsRichard P Baum, Harshad R Kulkarni, Aviral Singh, et al.
Scientific Reports|March 20, 2019
Stability of radiomics features in apparent diffusion coefficient maps from a multi-centre test-retest trialJurgen Peerlings, Henry C Woodruff, Jessica M Winfield, et al.
Journal for Immunotherapy of Cancer|March 10, 2021
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapyVeronica Olivo Pimentel, Damiënne Marcus, Alexander Ma van der Wiel, et al.
Scientific Reports|August 6, 2015
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysisRalph T H Leijenaar, Georgi Nalbantov, Sara Carvalho, et al.
Pageof 94